Equifax Inc.
NYSE:EFXConsulting Services
-$0.93 today
- Market cap
- $21.02B
- Beta
- 1.31
- P/E (TTM)
- 26.4
- EPS (TTM)
- $5.82
- Dividend yield
- 1.38%
Volume 1.13M
Average 1.76M
EFX Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Equifax Inc.NYSE: EFX
Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026
Cash & equivalents rises 2.1% from a year ago
Cash & equivalents stood at $192.9M at the end of Q3 FY2026, up 2.1% from a year earlier and up 13.4% from the prior quarter. Over 3 fiscal years it compounded at -14.1% a year.
Context
- Cash & equivalents amounted to 1.6% of total assets at the end of Q3 FY2026, unchanged from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +2.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 180.8M USD
- Year-over-year change
- +6.4%
- 4-year CAGR
- -5.3%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 180.8M | +6.4% |
| FY2024 | 2024-12-31 | 169.9M | -21.6% |
| FY2023 | 2023-12-31 | 216.8M | -24.0% |
| FY2022 | 2022-12-31 | 285.2M | +26.9% |
| FY2021 | 2021-12-31 | 224.7M | — |
Cash & Equivalents vs competitors
How EFX compares with its peers on the latest reported figures
- EFX's Sep 2026 cash & equivalents of $192.9M is the 7th highest of the 10 companies compared; the peer median is $334M.
- Its year-over-year change of +2.1% is the 4th highest of 10, against a peer median of -12.3%.
- Cash & equivalents amounts to 1.6% of total assets for EFX, versus a peer median of 6.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $4.14B | +124.2% | +10.7% | 6.6% | |
| Jun 2026 | $839.1M | +22.1% | +13.4% | 6.9% | |
| Aug 2026 | $600.9M | -25.7% | -2.3% | 3.8% | |
| Jun 2026 | $551.4M | -12.3% | +168.5% | 12.3% | |
| Sep 2026 | $334M | -59.1% | +21.6% | 4.0% | |
| Jun 2026 | $324.71M | -14.7% | -11.0% | 11.4% | |
| Sep 2026 | $192.9M | +2.1% | -14.1% | 1.6% | |
| Jun 2026 | $163.75M | +7.1% | -18.6% | 4.6% | |
| Mar 2026 | $73.9M | -2.2% | -19.9% | 18.1% | |
| Mar 2026 | $3.88M | -32.1% | -22.2% | 0.2% | |
| Peer median (excluding EFX) | $334M | -12.3% | -2.3% | 6.6% | |
Competitors are the stored peer set for EFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 224.7M | 285.2M | 216.8M | 169.9M | 180.8M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 727.6M | 857.7M | 908.2M | 957.6M | 1.01B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 60.2M | 93.3M | 88.8M | 98.2M | 74.5M |
| Total Current Assets | 1.12B | 1.37B | 1.36B | 1.36B | 1.41B |
| Property, Plant & Equipment (Net) | 1.32B | 1.59B | 1.83B | 1.89B | 1.93B |
| Goodwill | 6.26B | 6.38B | 6.83B | 6.55B | 6.75B |
| Intangible Assets | 1.99B | 1.91B | 1.95B | 1.62B | 1.43B |
| Long-term Investments | 127.7M | 74.5M | 88.9M | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 225.4M | 218.7M | 217.3M | 343.4M | 347.8M |
| Total Non-current Assets | 9.92B | 10.18B | 10.92B | 10.4B | 10.45B |
| Total Assets | 11.04B | 11.55B | 12.28B | 11.76B | 11.86B |
| Account Payables | 211.6M | 250.8M | 197.6M | 138.2M | 206.4M |
| Short-term Debt | 824.8M | 967.2M | 963.4M | 687.7M | 1.04B |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 121.3M | 132.9M | 109.5M | 115.5M | 101.2M |
| Other Current Liabilities | 638.2M | 296.6M | 334.7M | 403.2M | 427.4M |
| Total Current Liabilities | 2.29B | 2.02B | 2.02B | 1.81B | 2.34B |
| Long-term Debt | 4.47B | 4.82B | 4.75B | 4.32B | 4.06B |
| Deferred Tax Liabilities | 358.2M | 460.3M | 474.9M | 351.6M | 390.8M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 320.1M | 279M | 350.8M | 353.9M | 344.5M |
| Total Non-current Liabilities | 5.15B | 5.56B | 5.57B | 5.03B | 4.79B |
| Total Liabilities | 7.44B | 7.57B | 7.59B | 6.84B | 7.13B |
| Common Stock | 236.6M | 236.6M | 236.6M | 236.6M | 236.6M |
| Retained Earnings | 4.75B | 5.26B | 5.61B | 6.02B | 6.45B |
| Accumulated OCI | (295.4M) | (473.7M) | (431.2M) | (722.7M) | (517.1M) |
| Other Stockholders Equity | (5.9M) | (5.9M) | (5.9M) | (5.9M) | (5.9M) |
| Minority Interest | 16.8M | 16.8M | 153.4M | 122.7M | 133.9M |
| Total Equity | 3.6B | 3.97B | 4.69B | 4.92B | 4.74B |
| Total Debt | 5.29B | 5.79B | 5.71B | 5.01B | 5.09B |
| Net Debt | 5.07B | 5.5B | 5.49B | 4.84B | 4.91B |
Equifax Inc.
NYSE:EFX
Intrinsic Alpha fair value
Locked
Current Price
$179.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.